The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1471, doi. 10.1002/pros.23872
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 12
Results: 14
1
2
Concentration‐dependent effects of dutasteride on prostate‐specific membrane antigen (PSMA) expression and uptake of <sup>177</sup>Lu‐PSMA‐617 in LNCaP cells.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1450, doi. 10.1002/pros.23868
- By:
- Publication type:
- Article
3
Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1439, doi. 10.1002/pros.23866
- By:
- Publication type:
- Article
4
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1386, doi. 10.1002/pros.23861
- By:
- Publication type:
- Article
5
A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1378, doi. 10.1002/pros.23844
- By:
- Publication type:
- Article
6
RE: Joentausta et al. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583‐591.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1399, doi. 10.1002/pros.23862
- By:
- Publication type:
- Article
7
MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1422, doi. 10.1002/pros.23871
- By:
- Publication type:
- Article
8
Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583–591.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1420, doi. 10.1002/pros.23870
- By:
- Publication type:
- Article
9
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1462, doi. 10.1002/pros.23865
- By:
- Publication type:
- Article
10
Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1457, doi. 10.1002/pros.23864
- By:
- Publication type:
- Article
11
Access and concentrations of atorvastatin in the prostate in men with prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1412, doi. 10.1002/pros.23863
- By:
- Publication type:
- Article
12
A novel androgen‐reduced prostate‐specific lncRNA, PSLNR, inhibits prostate‐cancer progression in part by regulating the p53‐dependent pathway.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1362, doi. 10.1002/pros.23840
- By:
- Publication type:
- Article
13
The metastasis suppressor CD82/KAI1 represses the TGF‐β <sub>1</sub> and Wnt signalings inducing epithelial‐to‐mesenchymal transition linked to invasiveness of prostate cancer cells.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1400, doi. 10.1002/pros.23837
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- Prostate, 2019, v. 79, n. 12, p. 1361, doi. 10.1002/pros.23679
- Publication type:
- Article